A groundbreaking study has identified two proteins that interact with a mutant FUS variant linked to familial amyotrophic lateral sclerosis (ALS), offering a potential therapeutic target. Researchers found that inhibiting these proteins in motor neurons derived from human stem cells reduced ALS-related changes, suggesting similar mechanisms may be involved in sporadic ALS.
Key Takeaways
Inhibiting…
